NCI, Inc. (NASDAQ:NCIT)‘s stock had its “buy” rating reissued by SunTrust Banks, Inc. in a report released on Monday.
A number of other brokerages also recently weighed in on NCIT. Noble Financial reissued a “buy” rating on shares of NCI in a report on Friday, May 12th. Zacks Investment Research raised shares of NCI from a “sell” rating to a “hold” rating in a report on Saturday, May 13th. Cowen and Company reissued a “buy” rating and issued a $16.50 price target on shares of NCI in a report on Monday, April 10th. FBR & Co reissued a “hold” rating and issued a $11.00 price target on shares of NCI in a report on Tuesday, April 4th. Finally, ValuEngine raised shares of NCI from a “hold” rating to a “buy” rating in a report on Friday, June 2nd. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $17.50.
NCI (NCIT) traded up 1.72% during trading on Monday, hitting $20.75. 3,910 shares of the company traded hands. The firm has a 50 day moving average of $18.39 and a 200 day moving average of $15.07. NCI has a one year low of $10.98 and a one year high of $21.00. The firm has a market cap of $281.18 million, a P/E ratio of 46.42 and a beta of 0.98.
NCI (NASDAQ:NCIT) last issued its quarterly earnings results on Tuesday, May 9th. The information technology services provider reported $0.25 earnings per share for the quarter, beating analysts’ consensus estimates of $0.21 by $0.04. NCI had a net margin of 2.13% and a return on equity of 11.73%. The firm had revenue of $78.75 million during the quarter, compared to the consensus estimate of $76.55 million. On average, analysts expect that NCI will post $1.01 earnings per share for the current fiscal year.
WARNING: This piece was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international trademark and copyright law. The legal version of this piece can be read at https://sportsperspectives.com/2017/06/26/ncis-ncit-buy-rating-reiterated-at-suntrust-banks-inc.html.
Institutional investors have recently made changes to their positions in the stock. Royce & Associates LP acquired a new position in shares of NCI during the first quarter worth about $7,663,000. ClariVest Asset Management LLC boosted its position in shares of NCI by 5.3% in the first quarter. ClariVest Asset Management LLC now owns 14,464 shares of the information technology services provider’s stock worth $217,000 after buying an additional 727 shares in the last quarter. Hancock Holding Co. acquired a new position in shares of NCI during the first quarter worth about $189,000. Bank of New York Mellon Corp boosted its position in shares of NCI by 4.4% in the first quarter. Bank of New York Mellon Corp now owns 27,972 shares of the information technology services provider’s stock worth $421,000 after buying an additional 1,184 shares in the last quarter. Finally, Algert Global LLC boosted its position in shares of NCI by 10.8% in the first quarter. Algert Global LLC now owns 12,155 shares of the information technology services provider’s stock worth $183,000 after buying an additional 1,180 shares in the last quarter. Institutional investors own 39.04% of the company’s stock.
NCI Company Profile
NCI, Inc is a provider of enterprise services and solutions to defense, intelligence, healthcare and civilian government agencies. The Company provides information technology (IT), and professional services and solutions by leveraging its core service offerings, which include cloud computing and IT infrastructure optimization; cybersecurity and information assurance; engineering and logistics support; enterprise information management and advanced analytics; health IT and medical support; IT service management; modeling, simulation, and training, and agile development and integration.
Receive News & Ratings for NCI Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCI Inc. and related companies with MarketBeat.com's FREE daily email newsletter.